Merck & Company Inc (NYSE:MRK) — Stock Price
Merck & Company Inc (NYSE:MRK) is currently trading at $130.92 USD, up 1.82% today. Over the past 52 weeks, shares have ranged between $77.60 and $131.82. This page tracks Merck & Company Inc's live share price on the NYSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market value of Merck & Company Inc.
Merck & Company Inc (MRK) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Merck & Company Inc's daily closing share price and trading volume on the NYSE exchange over the past year, giving a clear view of recent price momentum and liquidity.
Merck & Company Inc Income Statement — Revenue, Profit & Earnings by Year
Merck & Company Inc's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | $64.93 Billion | $64.17 Billion | $60.12 Billion | $59.28 Billion | $48.70 Billion |
| Cost of Revenue | $18.20 Billion | $15.19 Billion | $16.13 Billion | $17.41 Billion | $13.63 Billion |
| Gross Profit | $46.73 Billion | $48.98 Billion | $43.99 Billion | $41.87 Billion | $35.08 Billion |
| Research & Development | $12.51 Billion | $17.94 Billion | $30.53 Billion | $13.55 Billion | $12.24 Billion |
| SG&A | $10.61 Billion | $7.70 Billion | $7.58 Billion | $7.47 Billion | $7.40 Billion |
| Total Operating Expenses | $23.25 Billion | $28.75 Billion | $41.03 Billion | $23.59 Billion | $21.88 Billion |
| Operating Income | $23.49 Billion | $20.22 Billion | $2.95 Billion | $18.28 Billion | $13.20 Billion |
| EBITDA | $28.26 Billion | $25.71 Billion | $6.91 Billion | $21.32 Billion | $17.90 Billion |
| EBIT | $22.42 Billion | $21.21 Billion | $3.04 Billion | $17.41 Billion | $14.69 Billion |
| Interest Expense | $1.36 Billion | $1.27 Billion | $1.15 Billion | $962.00 Million | $806.00 Million |
| Income Before Tax | $21.07 Billion | $19.94 Billion | $1.89 Billion | $16.44 Billion | $13.88 Billion |
| Income Tax Expense | $2.80 Billion | $2.80 Billion | $1.51 Billion | $1.92 Billion | $1.52 Billion |
| Net Income | $18.25 Billion | $17.12 Billion | $365.00 Million | $14.52 Billion | $13.05 Billion |
Merck & Company Inc Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Merck & Company Inc's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | $136.87 Billion | $117.11 Billion | $106.67 Billion | $109.16 Billion | $105.69 Billion |
| Total Current Assets | $43.52 Billion | $38.78 Billion | $32.17 Billion | $35.72 Billion | $30.27 Billion |
| Cash & Equivalents | $14.56 Billion | $13.24 Billion | $6.84 Billion | $12.69 Billion | $8.10 Billion |
| Short-term Investments | $0.00 | $447.00 Million | $252.00 Million | $498.00 Million | $0.00 |
| Net Receivables | $12.68 Billion | $10.28 Billion | $10.35 Billion | $9.45 Billion | $9.23 Billion |
| Inventory | $6.66 Billion | $6.11 Billion | $6.36 Billion | $5.91 Billion | $5.95 Billion |
| Property, Plant & Equipment | $26.82 Billion | $25.15 Billion | $24.49 Billion | $21.42 Billion | $19.28 Billion |
| Goodwill | $21.58 Billion | $21.67 Billion | $21.20 Billion | $21.20 Billion | $21.26 Billion |
| Total Liabilities | $84.20 Billion | $70.73 Billion | $69.04 Billion | $63.10 Billion | $67.44 Billion |
| Total Current Liabilities | $28.33 Billion | $28.42 Billion | $25.69 Billion | $24.24 Billion | $23.87 Billion |
| Long-term Debt | $46.75 Billion | $34.46 Billion | $33.68 Billion | $28.75 Billion | $30.69 Billion |
| Net Debt | $35.97 Billion | $25.03 Billion | $29.43 Billion | $19.29 Billion | $26.54 Billion |
| Total Stockholder Equity | $52.61 Billion | $46.31 Billion | $37.58 Billion | $45.99 Billion | $38.18 Billion |
| Retained Earnings | $73.08 Billion | $63.07 Billion | $53.90 Billion | $61.08 Billion | $53.70 Billion |
Merck & Company Inc Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Merck & Company Inc generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | $16.47 Billion | $21.47 Billion | $13.01 Billion | $19.09 Billion | $14.11 Billion |
| Capital Expenditures | $4.11 Billion | $3.37 Billion | $3.86 Billion | $4.39 Billion | $4.45 Billion |
| Free Cash Flow | $12.36 Billion | $18.10 Billion | $9.14 Billion | $14.71 Billion | $9.66 Billion |
| Investing Cash Flow | $-13.74 Billion | $-7.73 Billion | $-14.08 Billion | $-4.96 Billion | $-16.55 Billion |
| Financing Cash Flow | $-1.92 Billion | $-7.03 Billion | $-4.81 Billion | $-9.12 Billion | $2.59 Billion |
| Dividends Paid | $-8.18 Billion | $-7.84 Billion | $-7.45 Billion | $7.01 Billion | $6.61 Billion |
| Stock-Based Compensation | $820.00 Million | $761.00 Million | $645.00 Million | $541.00 Million | $479.00 Million |
| Depreciation | $5.84 Billion | $4.50 Billion | $3.87 Billion | $3.91 Billion | $3.21 Billion |
| Change in Cash | $1.37 Billion | $6.41 Billion | $-5.86 Billion | $4.61 Billion | $14.00 Million |
Merck & Company Inc Earnings History — EPS Actual vs. Analyst Estimates
Track Merck & Company Inc's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Oct 29, 2026 | — | — | — |
| Aug 04, 2026 | — | -0.15 | — |
| Apr 30, 2026 | -1.28 | -1.47 | +12.93% |
| Feb 03, 2026 | 1.19 | 1.68 | -29.17% |
| Oct 30, 2025 | 2.58 | 2.35 | +9.79% |
| Jul 29, 2025 | 2.13 | 2.03 | +4.93% |
| Apr 24, 2025 | 2.22 | 2.14 | +3.74% |
| Feb 04, 2025 | 1.72 | 1.67 | +2.99% |